As shown in Fig. 3b, we found that overexpressed SHMT2 is associated with worse overall survival (OS) patients with renal clear cell carcinoma, with P = 0.033 and HR = 1.41 (1.03–1.94). This evidence concerns the gene SHMT2 and clear cell renal carcinoma.